Cadista Holdings Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY14 | FY13 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|---|
| Revenue | $107.7M | $114.9M | $91.0M | $42.2M | $28.8M |
| Operating income | $45.6M | $64.3M | $49.8M | $8.4M | $467,000 |
| Net income | $29.9M | $40.3M | $33.1M | $7.1M | $5.0M |
| Total assets | $138.1M | $107.9M | $68.5M | $36.4M | — |
| Total liabilities | $11.7M | $11.4M | $12.4M | $13.3M | — |
| Equity | $126.4M | $96.5M | $56.1M | $23.0M | $15.9M |
| EPS (diluted) | $0.25 | $0.34 | $0.28 | $0.06 | $0.04 |
| Shares out. | 117.8M | 117.8M | 117.8M | 117.8M | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2014- Operating margin
- 42.3%
- Net margin
- 27.8%
- Return on equity
- 23.7%
- Return on assets
- 21.7%
- Return on capital (ROCE)
- 35.8%
- Liabilities / assets
- 8.5%
- Debt / equity
- 0.09×
- Book value / share
- $1.07
- Revenue growth (YoY)
- −6.3%
- Net income growth (YoY)
- −25.8%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2014- Altman Z″ (distress)
- 20.63safe
- Accruals / assets
- 4.2%clean
- Beneish M-Score
- -2.47normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 1 warning● 6 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Revenue declined year-over-year
- Operating margin is positive
- Strong return on equity (>15%)
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Jul 1, 2013
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2012
- NT 10-Kmissed a reporting deadline ↗Jun 29, 2012
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Jubilant Life Sciences Ltd.10% owner | Dec 22, 2014 | Buy | 20.8M | $1.60 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Entered a material agreementNov 25, 2014
- Amended charter or bylawsOct 9, 2014
- Director / officer changeOct 7, 2014
- Entered a material agreementAug 15, 2014
- Entered a material agreement · Director / officer changeAug 12, 2014
- Director / officer changeAug 5, 2014
- Director / officer changeJun 20, 2014
- Amended charter or bylawsMay 27, 2014
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13DDec 29, 2014
- 4FORM 4 SUBMISSIONDec 23, 2014
- 15-12GDec 23, 2014
- SC 13E3/ASC TO-T/ADec 22, 2014
- CORRESPDec 12, 2014
- SC 13E3/ADec 12, 2014
- SC 14D9/ADec 12, 2014
- SC 13E3/ASC TO-T/ADec 11, 2014
- UPLOADDec 9, 2014
- SC 13E3/ADec 5, 2014
- SC 14D9/ADec 5, 2014
- CORRESPDec 4, 2014
- SC 13E3/AFORM SC TO-T/ADec 3, 2014
- UPLOADNov 26, 2014
- UPLOADNov 26, 2014
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.